Navicare Biotech , Ltd. Current Cash

Navicare Biotech , Ltd. (8472.TWO) currently reports a current cash of $68M as of June 2026. That compares with $190M in the prior-year period — down 64.3% year over year. Use the charts on this page to explore Navicare Biotech , Ltd.'s current cash history and peer comparisons.

Navicare Biotech , Ltd.'s current cash decreased from $190M to $68M — a 64.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Navicare Biotech , Ltd. reported $68M in current cash as of June 2026. That compares with $190M in the prior-year period — down 64.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $68M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Navicare Biotech , Ltd., and consider following 8472.TWO for alerts when major investors trade the stock.